Journal article icon

Journal article

A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19

Abstract:

Background No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2.

Methods We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao2) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao2) to the fracti...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1056/nejmoa2001282

Authors


Expand authors...
Wellcome Trust More from this funder
Publisher:
Massachusetts Medical Society Publisher's website
Journal:
New England Journal of Medicine Journal website
Volume:
382
Issue:
19
Pages:
1787-1799
Publication date:
2020-03-18
DOI:
EISSN:
1533-4406
ISSN:
0028-4793
Pmid:
32187464
Language:
English
Keywords:
Pubs id:
1095098
Local pid:
pubs:1095098
Deposit date:
2020-06-03

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP